Ashley Ghiaseddin, M.D., chief of the Division of Neuro-Oncology in the UF Department of Neurosurgery, has been elected secretary of the Florida Society of Clinical Oncology (FLASCO).
Ghiaseddin was named to this key Executive Committee position during FLASCO’s 2025 Fall Oncology Congress in Orlando this weekend, where he was also honored with the FLASCO Above and Beyond Award.
“Being elected an officer for FLASCO is an honor,” Ghiaseddin said. “FLASCO has been a leader in supporting oncology providers and patients alike. Their influence in the state for advocacy and education has directly benefited the care we provide our patients.”
Ghiaseddin said he plans to help continue the growth of research grant support that FLASCO provides early-career investigators, driving innovation in cancer care across the state.
“This initiative was a pillar of Dr. Maen Hussein’s FLASCO presidency and I want to continue this momentum in supporting cancer research within the state,” Ghiaseddin said. “It’s an honor to represent our Cancer Center and the Preston A. Wells Jr. Center for Brain Tumor Therapy at FLASCO. I’m grateful for Drs. Jonathan Licht, Thomas George, Duane Mitchell and Brian Hoh for their leadership and support. I want to enhance the partnership between UF and FLASCO, with the goal to improve the lives of our patients.”
Ghiaseddin has been a dedicated and active member of FLASCO for several years, serving as the oncology captain for neuro-oncology. He has been instrumental in supporting numerous initiatives, including advocacy, corporate projects and board involvement. Last year, he was named the December Member of the Month.
At the UF Health Cancer Center, he serves as clinical leader of the neurology disease site group. A clinical associate professor, he specializes in brain cancer treatment, using targeted methods including chemotherapy, immunotherapy and precision medicine for patients with malignant brain tumors.
Congratulations, Dr. Ghiaseddin!
